Attenuation of microcirculatory disturbance after liver ischemia by newly synthesized inflammatory cytokine suppressor, FR167653

Hepato-Gastroenterology

Volumn 50, Issue 51, 2003, Pages 789-793

  Takiguchi, Makoto ^a   Totsuka, Eishi ^a   Umehara, Minoru ^a   Ono, Hiroaki ^a   Nara, Masaki ^a   Nozaki, Tsuyoshi ^a   Wajima, Naoki ^a   Takahashi, Katsuro ^a   Narumi, Shunji ^a   Hakamada, Kenichi ^a   Sugai, Michihiro ^a   Sasaki, Mutsuo ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Cytokine; FR167653; Liver ischemia; Microcirculatory disturbance

Indexed keywords

1 [7 (4 FLUOROPHENYL) 1,2,3,4 TETRAHYDRO 8 (4 PYRIDYL)PYRAZOLO[5,1 C][1,2,4]TRIAZIN 2 YL] 2 PHENYLETHANEDIONE; ANTIINFLAMMATORY AGENT; CYTOKINE; ENDOTHELIN 1; INTERLEUKIN 1BETA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DOG; HYPERCOAGULABILITY; LIVER BIOPSY; LIVER BLOOD FLOW; LIVER FUNCTION TEST; LIVER ISCHEMIA; MICROCIRCULATION; NONHUMAN; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; REPERFUSION INJURY; SURVIVAL RATE; THROMBOCYTE AGGREGATION; THROMBOEMBOLISM; TREATMENT OUTCOME;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOGS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; INTERLEUKIN-1; ISCHEMIA; LIVER; LIVER FUNCTION TESTS; MICROCIRCULATION; PREMEDICATION; PYRAZOLES; PYRIDINES; REGIONAL BLOOD FLOW; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0038577544     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Suzuki S, Toledo-Pereyra LH, Rodriguez F, Lopez F: Role of Kupffer cells in neutrophil activation and infiltration following total hepatic ischemia and reperfusion. Circ Shock 1994; 42:204-209.
2. Welbourn CRB, Goldman G, Paterson IS, Valeri CR, Shepro D, Hechtman HB: Pathophysiology of ischemia reperfusion injury: central role of the neutrophil. Br J Surg 1991; 78:651-655.
3. Toledo-Pereyra LH, Suzuki S: Cellular and biomolecular mechanisms of liver ischemia and reperfusion injury. Transplant Proc 1994; 26:325-327.
4. Jaeschke H, Farwood A, Smith CW: Neutrophiis contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 1990; 4:3355-3359.
5. Baudry N, Rasetti C, Vicaut E: Differences between cytokines effects in the microcirculation of the rat. Am J Physiol 1996; 271:1186-1192.
6. Lentsch AB, Miller FN, Edwards MJ: Interleukin-2-induced hepatic injury involves temporal patterns of cell adhesion in the microcirculation. Am J Physiol 1997; 272:727-731.
7. Suzuki N, Matsumoto H, Kitada C, Masaki T, Fujino M: A sensitive sandwich-enzyme immunoassay for human endothelin. J Immunol Methods 1989; 118:245-250.
8. Declerck PJ, Alessi MC, Verstreken M, Kruithof EKO, Juhan-Vague I, Collen D: Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 1988; 71:220-225.
9. Harvey PRC, Iu S, McKeown CMB, Petrunka CN, Ilson RG, Strasberg SM: Adenine nucleotide tissue concentrations and liver allograft viability after cold preservation and warm ischemia. Transplantation 1988; 45:1016-1020.
10. Hamamoto N, Sakai F, Yamazaki H, Nakahara K, Okuhara M: Effect of FR167653, a cytokine suppressive agent, on endotoxin-induced disseminated intravascular coagulation. Eur J Pharmacol 1996; 314:137-142.
11. Yamamoto N, Sakai F, Yamazaki H, Natsuki S, Nakahara K, Okuhara M: FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor-alpha, ameliorates endotoxin-induced shock. Ear J Pharmacol 1997; 327:169-175.
12. Kamoshita N, Takeyoshi I, Ohwada S, Iino Y, Morishita Y: The effects of FR167653 on pulmonary ischemia-reperfusion injury in dogs. J Heart Lung Transplant 1997; 16:1062-1072.
13. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW: A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994; 372:739-746.
14. Takeyoshi I, Otani Y, Koibuchi Y, Yokoe T, Iino Y, Matsumoto K, Muramoto M, Satoh S, Morishita Y: Effects of FR167653 on pulmonary ischemia-reperfusion injury. Administration timing. Transplant Proc 1999; 31:1935-1936.
15. Imakita M, Yamanaka N, Kuroda N, Kitayama Y, Sasaki S, Nakagaki I, Hori S, Okamoto E: Effects of the endothelin receptor antagonist TAK-044 on hepatocyte element alteration in the ischemic-reperfused liver in Beagle dogs. J Hepatol 1998; 28:204-211.
16. Wood JG, Yan ZY, Zhang Q, Cheung LY: Ischemia-reperfusion increases gastric motility and endothelin-1-induced vasoconstriction. Am J Physiol 1995; 269:G524-531.
17. Kahaleh MB, Fan PS: Effect of cytokines on the production of endothelin by endothelial cells. Clin Exp Rheumatol 1997; 15:163-167.
18. Benvenisti J, Chignard M: A role of PAF-acether in platelet dependent vascular diseases? Circulation 1985; 72:713-717.
19. Hamburger SA, McEver RP: GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood 1990; 75:550-554.
20. Read MA, Neish AS, Luscinskas FW, Palombella VJ, Maniatis T, Collins T: The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity 1995; 2:493-596.
21. Sprengers ED, Kluft C: Plasminogen activator inhibitors. Blood 1987; 69:381-387.
22. van Hinsbergh VWM, Kooistra T, van den Berg EA, Princen HMG, Fiers W, Emeis JJ: Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood 1988; 72:1467-1473.